<DOC>
	<DOC>NCT02355639</DOC>
	<brief_summary>The purpose of this study is to assess steroid induced skin atrophy by sonography.</brief_summary>
	<brief_title>A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Connective Tissue Diseases</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<mesh_term>Petrolatum</mesh_term>
	<criteria>1. Healthy male volunteers, 25 to 40 years old inclusive. 2. Healthy skin on volar arms with a hairless area sufficient for measurements 1. Clinical skin atrophy, telangiectasia or striae on volar arms. 2. Presence of any skin condition or colouration that would interfere with test sites or the response or assessment. 3. Fitzpatrick skin type IV VI. 4. History or current evidence of infection, eczema or other relevant skin disease.</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>